Interestingly, even if marginally significant, a lower percentage of MES cells was observed among patients with liver localizations and CNS involvement.
← all excerpts
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
1
—
—